All Biotech News

List of articles in category All Biotech News
Title	Published Date
Orchard Therapeutics Launches and Announces Academic Partnerships for Development of Transformative Gene Therapies	05/03/2016
CyTuVax Reports Interim Results of the Phase I Clinical Trial with the HBAI20 Hepatitis B Vaccine for Non-Responders	04/29/2016
Cristal Therapeutics Announces Appointment of Edwin Klumper as Chief Medical Officer	04/29/2016
VTU Technology and Boehringer Ingelheim Strengthen Their Global Microbial Technology Collaboration	04/27/2016
ProBioGen and Eucodis Sign Agreement to Commercialize C-LiNK, a Novel Antibody Drug Conjugation Technology	04/19/2016
Agendia’s MammaPrint® First and Only Genomic Assay to Receive Level 1A Clinical Utility Evidence for Chemotherapy Benefit in Early Breast Cancer Patients	04/19/2016
RedHill Biopharma Announces Positive FDA Meeting on RHB-105 Path to Approval and Planned Confirmatory Phase III Study for H. pylori Infection	04/18/2016
Selvita Files IND Application for its Novel, Dual PIM/FLT3 Inhibitor in AML	04/18/2016
MINDACT Trial Findings on Agendia’s MammaPrint to be Presented during AACR Annual Meeting 2016	04/15/2016
Apollo Therapeutics: Dr Richard Butt Appointed CEO	04/14/2016
Tech Transfer: 9th BioVaria to Take Place in Munich on 17 May 2016	04/13/2016
Susanne Resatz, President of Vetter Development Services USA, Inc. is Elected to the Board of Directors of the German American Chamber of Commerce® of the Midwest, Inc.	04/12/2016
RedHill Biopharma Initiates Phase II Study of BEKINDA™ for Irritable Bowel Syndrome	04/12/2016
Forbion Closes Third Life Sciences Fund, FCF III, Raising over USD200M	04/12/2016
4th Laupheim Biotech Days to Take Place June 13 to 14, 2016	04/11/2016
Adherium Appoints Senior Executive to Lead Market Expansion and Establishes European Operations	04/04/2016
RedHill Biopharma Announces Interim Results from Phase IIa Proof-of-Concept Study Supporting Therapeutic Potential of RHB-104 in Multiple Sclerosis	04/01/2016
Zytoprotec Appoints Joerg Vienken and Norbert Riedel to Supervisory Board	03/30/2016
Amal Therapeutics Raises CHF 3 Million in a Series A Financing Round Led by Boehringer Ingelheim Venture Fund	03/30/2016
ITM and Scil Proteins Announce New Partnership for Targeted Radio Conjugates	03/24/2016
Vetter Groundbreaking Ceremony Heralds the Creation of a New 70 Million Euro Production Building	03/22/2016
BioPharmaSpec Announces Expansion into Asia with New Business Development Teams	03/21/2016
ModiQuest Research and Sobi™ to Continue their Collaboration on Antibody Generation	03/16/2016
LifeCodexx AG Enhances PrenaTest® Availability in Switzerland and Germany through Successful Technology Transfers and Strategic Partnerships	03/16/2016
Selvita Bridges Krakow and San Francisco	03/11/2016
OncoQR ML GmbH and TYG Oncology, Ltd Expand their Collaboration Against Cancers	03/11/2016
Taconic Biosciences Hosts Symposia Series on Advanced Preclinical Models for Immuno-Oncology and Infectious Disease	03/10/2016
Agendia to Highlight New MammaPrint Data at the 2016 European Breast Cancer Conference as a Prelude to Upcoming MINDACT Trial Findings	03/08/2016
ITM Announces Successful Fundraising of 20 Million EUR	03/07/2016
New Understanding of the Mechanism of Neurodegeneration Leads to a Novel Approach to Treatment for Alzheimer’s Disease	03/01/2016

Page 44 of 84